glp 1 weight loss medications Medication vs. Bariatric Surgery for Loss: Options Matter GLP-1 Medications Now Recommended First

Gastrointestinal Adverse Events Of the adverse effects reported during GLP-1 RA clinical trials, gastrointestinal symptoms were the most frequent, with nausea and diarrhea very common, and vomiting, constipation, abdominal pain, and dyspepsia considered to be relatively common [97]

PMID 4932997

The favorable safety profile of tesofensine, demonstrated in this trial and previous studies, adds to the potential of Tesomet in treating conditions like Prader-Willi syndrome and hypothalamic obesity

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

Biol Psychiatry Glob Open Sci